Early research (Phase 1)Study completedNCT01598129What this trial is testingONCOS-102 (Previously CGTG-102) for Therapy of Advanced CancersWho this might be right forMalignant Solid Tumour Targovax Oy 12
Early research (Phase 1)Ended earlyNCT04099277What this trial is testingLY3435151 in Participants With Solid TumorsWho this might be right forSolid TumorTriple-negative Breast CancerGastric Adenocarcinoma+6 more Eli Lilly and Company 2
Testing effectiveness (Phase 2)Study completedNCT03213665What this trial is testingTazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Hodgkin LymphomaAnn Arbor Stage III Non-Hodgkin Lymphoma+38 more National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT04175847What this trial is testingA Phase I /IIa Study of RC88-ADC in Subjects With Advanced Malignant Solid TumorsWho this might be right forSolid Tumor RemeGen Co., Ltd. 198
Testing effectiveness (Phase 2)Looking for participantsNCT05991583What this trial is testingA Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant TumorsWho this might be right forAdvanced Malignant Tumors SUNHO（China）BioPharmaceutical CO., Ltd. 25
Early research (Phase 1)Study completedNCT03831295What this trial is testingSD-101 and BMS-986178 in Treating Patients With Advanced or Metastatic Solid MalignanciesWho this might be right forAdvanced Malignant Solid NeoplasmExtracranial Solid NeoplasmMetastatic Malignant Solid Neoplasm Ronald Levy 12
Early research (Phase 1)Study completedNCT01001936What this trial is testingStudy Evaluating SKI-606 in Subject With Solid TumorsWho this might be right forTumors Wyeth is now a wholly owned subsidiary of Pfizer 28
Early research (Phase 1)UnknownNCT06462716What this trial is testingA Phase l Study of By101298, an Oral DNA-PK Inhibitor, in Patients With Advanced Solid TumorsWho this might be right forSolid Tumor, Adult Chengdu Baiyu Pharmaceutical Co., Ltd. 36
Early research (Phase 1)Study completedNCT00026169What this trial is testingImatinib Mesylate in Treating Patients With Advanced Cancer and Kidney FailureWho this might be right forMalignant NeoplasmUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI) 69
Testing effectiveness (Phase 2)Ended earlyNCT04260802What this trial is testingEvaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersWho this might be right forCancerNeoplasmsMetastatic Cancer+16 more Ocellaris Pharma, Inc. 73
Early research (Phase 1)Looking for participantsNCT06383871What this trial is testingA Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant TumourWho this might be right forAdvanced Malignant Tumour Shandong Suncadia Medicine Co., Ltd. 233
Early research (Phase 1)Looking for participantsNCT07121036What this trial is testingHigh - Dose Vitamin C Infusion Regimen Based on Pharmacokinetic Characteristics for Patients With Advanced Malignant Solid TumorsWho this might be right forVitamin C Zhongnan Hospital 18
Early research (Phase 1)Study completedNCT00638898What this trial is testingBusulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid TumorWho this might be right forSolid TumorAdult Central Nervous System Germ Cell TumorAdult Rhabdomyosarcoma+27 more City of Hope Medical Center 25
Early research (Phase 1)Study completedNCT05116709What this trial is testingAssessment of Safety and Preliminary Clinical Efficacy with BAT6005 in Advanced Malignant Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumors Bio-Thera Solutions 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT04266912What this trial is testingAvelumab and M6620 for the Treatment of DDR Deficient Metastatic or Unresectable Solid TumorsWho this might be right forMetastatic Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmUnresectable Malignant Solid Neoplasm M.D. Anderson Cancer Center 23
Early research (Phase 1)Not Yet RecruitingNCT07482319What this trial is testingA Clinical Study GK01 Injection in Subjects With Advanced Malignant Solid TumorsWho this might be right forAdvanced Solid Tumors Beijing Geekgene Technology Co., LTD 15
Early research (Phase 1)Ended earlyNCT02317419What this trial is testingRO6927005 Either As Monotherapy (Part A) or in Combination With Gemcitabine and Nab-Paclitaxel (Part B) to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Clinical Activity in Patients With Mesothelin-positive Metastatic and/or Locally Advanced Malignant Solid TumorsWho this might be right forCancer Hoffmann-La Roche 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03583255What this trial is testingPhysical Activity With or Without Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Locally Advanced, Metastatic, or Recurrent CancerWho this might be right forAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid System NeoplasmLocally Advanced Malignant Solid Neoplasm+2 more M.D. Anderson Cancer Center 99
Early research (Phase 1)Study completedNCT06231550What this trial is testingAxl Inhibitor FC084CSA in Patients With Advanced Malignant Solid TumorsWho this might be right forAdvanced Malignant Solid Tumors FindCure Biosciences (ZhongShan) Co., Ltd. 21
Early research (Phase 1)UnknownNCT03662815What this trial is testingClinical Study of a Personalized Neoantigen Cancer Vaccine in Treating Patients With Advanced Malignant TumorWho this might be right forAdvanced Malignant Solid Tumor Sir Run Run Shaw Hospital 30